Amicus Therapeutics, Inc. (FRA:AM6)

Amicus Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,822	3,751	2,719	3,765	3,210	2,830
Market Cap Growth	36.25%	37.98%	-27.78%	17.29%	13.42%	-42.47%
Enterprise Value	3,948	3,904	2,907	3,922	3,300	2,727
Last Close Price	12.10	12.00	9.15	13.20	11.15	10.50
PS Ratio	7.08	6.95	5.33	10.42	10.42	10.53
PB Ratio	16.36	16.06	14.51	25.98	27.88	10.47
P/TBV Ratio	71.77	70.44	-	-	-	29.37
P/FCF Ratio	150.34	147.56	-	-	-	-
P/OCF Ratio	135.39	132.89	-	-	-	-
EV/Sales Ratio	7.33	7.23	5.70	10.86	10.71	10.15
EV/EBITDA Ratio	91.84	109.26	70.63	-	-	-
EV/EBIT Ratio	134.86	132.89	88.35	-	-	-
EV/FCF Ratio	155.31	153.56	-	-	-	-
Debt / Equity Ratio	1.61	1.61	2.29	2.78	3.67	1.43
Debt / EBITDA Ratio	8.73	8.73	8.61	-	-	-
Debt / FCF Ratio	14.82	14.82	-	-	-	-
Net Debt / Equity Ratio	0.54	0.54	1.00	0.99	1.29	-0.14
Net Debt / EBITDA Ratio	3.55	3.55	4.55	-2.42	-0.80	0.22
Net Debt / FCF Ratio	4.99	4.99	-5.17	-2.08	-0.93	0.21
Asset Turnover	0.73	0.73	0.68	0.53	0.40	0.34
Inventory Turnover	0.42	0.42	0.59	0.89	1.53	1.49
Quick Ratio	1.72	1.72	2.36	2.23	2.59	3.67
Current Ratio	2.84	2.84	3.39	2.88	3.05	4.09
Return on Equity (ROE)	-11.58%	-11.58%	-31.68%	-107.04%	-109.93%	-84.37%
Return on Assets (ROA)	2.48%	2.48%	2.72%	-6.12%	-15.68%	-13.95%
Return on Invested Capital (ROIC)	-1176.15%	-1207.57%	9.64%	-24.47%	-74.80%	-78.42%
Return on Capital Employed (ROCE)	4.80%	4.80%	5.40%	-12.00%	-34.90%	-26.30%
Earnings Yield	-0.60%	-0.61%	-1.99%	-3.64%	-6.90%	-7.78%
FCF Yield	0.67%	0.68%	-1.33%	-1.84%	-4.97%	-6.41%
Buyback Yield / Dilution	-1.31%	-1.31%	-3.12%	-2.11%	-6.50%	-4.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.